ProfileGDS4718 / 1570219_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 41% 37% 35% 42% 41% 43% 45% 42% 37% 37% 41% 36% 44% 40% 41% 39% 41% 38% 40% 44% 39% 38% 38% 36% 41% 42% 43% 39% 36% 46% 43% 41% 43% 40% 39% 43% 41% 39% 41% 34% 39% 46% 44% 40% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.0284941
GSM549102patient 115, normal, homogenized [OPG study]4.8837537
GSM549104patient 119, normal, homogenized [OPG study]4.756835
GSM549108patient 138, normal, homogenized [OPG study]5.1589842
GSM549119patient 077, normal, homogenized [OPG study]5.0435941
GSM549133patient 032, cancer, homogenized [OPG study]5.0577743
GSM549139patient 042, cancer, homogenized [OPG study]5.2229745
GSM549099patient 107, normal, homogenized [OPG study]5.0981342
GSM549109patient 139, normal, homogenized [OPG study]4.8884737
GSM549110patient 046, normal, homogenized [OPG study]4.8783837
GSM549114patient 063, normal, homogenized [OPG study]4.9752341
GSM549122patient 082, normal, homogenized [OPG study]4.8188436
GSM549134patient 033, cancer, homogenized [OPG study]5.1839944
GSM549136patient 036, cancer, homogenized [OPG study]4.9210440
GSM549140patient 044, cancer, homogenized [OPG study]4.9826441
GSM549111patient 047, normal, homogenized [OPG study]4.9202239
GSM549113patient 057, normal, homogenized [OPG study]5.0067241
GSM549132patient 031, cancer, homogenized [OPG study]4.8647538
GSM549137patient 038, cancer, homogenized [OPG study]4.9508940
GSM549142patient 047, cancer, homogenized [OPG study]5.3143744
GSM549100patient 110, normal, homogenized [OPG study]4.9480139
GSM549107patient 135, normal, homogenized [OPG study]4.8786838
GSM549115patient 068, normal, homogenized [OPG study]4.8370538
GSM549116patient 072, normal, homogenized [OPG study]4.7812736
GSM549120patient 078, normal, homogenized [OPG study]5.015341
GSM549131patient 030, cancer, homogenized [OPG study]5.0185342
GSM549118patient 074, normal, homogenized [OPG study]5.1469943
GSM549129patient 027, cancer, homogenized [OPG study]4.9378239
GSM549123patient 088, normal, homogenized [OPG study]4.7648436
GSM549124patient 006, cancer, homogenized [OPG study]5.3474246
GSM549126patient 015, cancer, homogenized [OPG study]5.1027743
GSM549128patient 025, cancer, homogenized [OPG study]4.9987441
GSM549103patient 117, normal, homogenized [OPG study]5.2030143
GSM549117patient 073, normal, homogenized [OPG study]4.9732440
GSM549138patient 041, cancer, homogenized [OPG study]4.9157139
GSM549141patient 045, cancer, homogenized [OPG study]5.0770143
GSM549130patient 028, cancer, homogenized [OPG study]5.0260841
GSM549101patient 111, normal, homogenized [OPG study]4.9942639
GSM549105patient 128, normal, homogenized [OPG study]5.0459241
GSM549106patient 134, normal, homogenized [OPG study]4.6557834
GSM549112patient 048, normal, homogenized [OPG study]4.9563139
GSM549125patient 011, cancer, homogenized [OPG study]5.2902346
GSM549127patient 024, cancer, homogenized [OPG study]5.2037244
GSM549135patient 035, cancer, homogenized [OPG study]4.9340540